Tarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $41 from $36 and keeps a Neutral rating on the shares.
Tarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $73 from $61 and keeps a Buy rating on the shares. The ...
AAON picks Memphis for its new data center cooling hub; 800 jobs to be created over 5 years
The new facility is expected to create more than 800 jobs over the next five years, with 291 jobs coming within the initial two-year ramp-up window (per the PILOT). The company will spend $93 million ...
5 Ways To Help Employees Find Purpose: Why It Matters More Than Perks
Five ways to help employees find purpose at work. Discover how conversations, job rotations, curiosity, and learning ...